echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > Sudden: Japanese Prime Minister Shinzo Abe has confirmed his resignation as his health deteriorates.

    Sudden: Japanese Prime Minister Shinzo Abe has confirmed his resignation as his health deteriorates.

    • Last Update: 2020-10-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    At a cabinet meeting at the prime minister's official residence at 5 p.m. (4 p.m. Beijing time) on Friday, Mr. Abe, who has been plagued for nearly 50 years, has said he intends to resign as prime minister to address health problems, and Mr. Abe has told officials of the ruling Liberal Democratic Party that he intends to resign.
    officials and Abe held an emergency meeting at the party headquarters to discuss the prime minister's decision.
    earlier, according to NHK, Abe plans to resign to avoid obstruction of state affairs because of deteriorating health.
    later cited people familiar with the matter as saying Mr Abe had decided to resign.
    Abe resigned as prime minister in September 2007 due to ulcerative colitis, but senior members of the ruling Liberal Democratic Party have previously stressed that although Abe's condition appears to have deteriorated, he is now recovering and is unlikely to resign.
    japanese media earlier reported that Abe suddenly vomited blood at work, while others reported that Abe was dizzy and vomiting on his way to work, with blood in his vomit.
    Abe went to Tokyo's Qingying University Hospital on August 24th and again after August 17th.
    prime minister's official residence that Abe was following a doctor's request to go to the hospital a week later.
    Japan's Yomiuri Shimbnews newspaper quoted sources as saying Abe's return to the hospital was to receive a medical report.
    Nippon TV quoted government and ruling party sources as saying Abe had gone to the hospital to treat chronic diseases, that ulcerative colitis may have worsened and that he had been treated in hospital.
    abe has been suffering from ulcerative colitis since he was 17 years old and has not fully recovered, with a history of 48 years.
    type of ulcerative colitis is a chronic inflammatory bowel disease caused by inflammation (swelling) of the large intestine.
    (typical) symptoms include abdominal pain, diarrhea, and tiredness.
    can cause endometrial ulcers in the colon and rectum.
    symptoms include diarrhea, abdominal cramps, weight loss and fatigue, and the long-term risk of colon cancer is higher than in people without ulcerative colitis.
    incidence is about 10 to 20 per 100,000 people per year.
    the cause of ulcerative colitis is not yet known, it is generally believed to work with genetic and immune system function abnormalities, in which the immune system attacks the digestive tract cell ulcerative colitis incidence peak is 20 to 30 years old, and 60 to 70 years old.
    eating irregularly and stress can aggravate the condition.
    may include an increased risk of colon cancer, vascular clots and colon perforation.
    ulcerative colitis usually does not affect the entire layer of the large intestine wall and almost never affects the small intestine.
    shallow ulcers in the affected large intestine.
    unlike Crohn's disease, ulcerative colitis does not cause fistula or abscesses.
    ulcerative colitis is currently incurable.
    most patients with ulcerative colitis (symptoms) can be alleviated, while first- or second-line treatment has no response (ineffective) to the rest of the patients.
    a large proportion of people are currently suffering from adverse effects.
    treatment for ulcerative colitis is to control inflammation, reduce symptoms and replenish any fluids and nutrients lost.
    treatment depends on the severity of the patient's symptoms.
    although corticosteroid hormone therapy is used in moderate to severe patients, this is not a long-term treatment because side effects may include bone loss, high blood pressure and weight gain.
    standard drugs: including 5-amino salginate (5-ASA) Asacol standard treatment.
    Abe said he started taking the drug in 2009, when it was approved in Japan.
    Sacol spends more time on the Japanese market, then I probably won't be what it is today," Shinzo Abe said in a 2013 speech.
    side effects of the drug, also known as mesharamin, may include nausea, headache or vomiting.
    rarely aggravates the symptoms of ulcerative colitis.
    other treatments include immunosuppressant drugs that require careful supervision and are usually used only when the patient is not responding to other treatments.
    treatment is surgical removal of the colon.
    Jiji Press, Reuters Medical Director Jack Source: MedSci Original Copyright Notice: All text, images and audio and video materials on this website that state "Source: Mets Medicine" or "Source: MedSci Original" are owned by Metz Medical and are not authorized to be reproduced by any media, website or individual.
    all reprinted articles on this website are for the purpose of transmitting more information and clearly indicate the source and author, and media or individuals who do not wish to be reproduced may contact us and we will delete them immediately.
    reproduce content at the same time does not represent the position of this site.
    leave a message here.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.